News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
The 2020-21 year has been unique and challenging, yet successful. The University community of students, faculty, and staff overcame significant obstacles to flourish.
By combining theory, computational simulations, chemical synthesis, and assembly, researchers demonstrate how an ‘inverse design’ strategy can create unique materials using difficult-to-mix nanocrysta
Interius BioTherapeutics just raised $76 million in seed funding to advance their clinical testing.
“The Penn transaction is an indicator that the entire region is benefiting from the research being done in our world-renowned institutions.”
Gain insight from Venture Capitalists who focus on investing in early stage University startups. Recorded on May 19, 2021.
Former I-Corps participant, and current PennovationWorks tenant, IQ Motion Control announced the launch of their newest line of servo motors, the Fortiq BLS42.
A two-year-old Philadelphia gene therapy company spun out of the University of Pennsylvania has raised $76 million
A low-cost, rapid diagnostic test for COVID-19 developed by Penn Medicine provides COVID-19 results within four minutes with 90% accuracy.
On May 6th, as part of the Cellicon Valley '21 two-day event, John Swartley, Managing Director of PCI, joined Penn Medicine faculty to discuss the commercialization of CAR-T technology
As part of Philly Tech Week 2021 and the Technical.ly Philly Introduced Conference, PCI and the Pennovation Center, hosted an educational webinar on the range of innovations emerging from Penn in the